Clinical Trials in Chicago

Showing 6561-6580 of 20,493 trials

Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)

NCT05452174

The primary objective of this proposal is to conduct an early Phase 2 clinical trial to determine the acceptability, dosing, tolerability and safety of mirtazapine for severe nausea and vomiting of pregnancy (sNVP) that is not adequately responsive to current standard treatments. This plan mirrors clinical practice since commonly prescribed antiemetic/ antinauseant drugs will be tested for efficacy before treating with mirtazapine.

PregnancySevere Nausea and VomitingHyperemesis Gravidarum

Northwestern UniversityStarted Jun 2022

Chicago, Illinois, United States

COMPLETEDNA2.2 miles

Honest, Open, Proud for Soldiers with Mental Illness

NCT03218748

The purpose of the study is to evaluate the feasibility and efficacy of the group-based intervention "Honest, Open, Proud" among soldiers with mental illness.

Mental Illness

University of Ulm99 participantsStarted Nov 2017

Chicago, Illinois, United States • Berlin, Germany • Ulm, Germany

COMPLETEDPhase 1/22.2 miles

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

NCT04020185

Open-label, dose escalation (Phase I) and dose expansion (Phase IIA) study of patients receiving intra-tumoral IMSA101 alone or in combination with an immune checkpoint inhibitor (ICI) (Phase I and II)

Solid Tumor, Adult

ImmuneSensor Therapeutics Inc.40 participantsStarted Sep 2019

Scottsdale, Arizona, United States • La Jolla, California, United States • Chicago, Illinois, United States +3 more locations

Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP)

Honest, Open, Proud for Soldiers with Mental Illness

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Find Trials by Condition in Chicago

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Prospective Evaluation of Efficacy and Safety of an Intense Pulsed Light Device to Treat Dry Eye Disease"

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)

Comprehensive Outcomes for After Cancer Health

A Phase III Trial of e-TNS for the Acute Treatment of Migraine

Osia 2 Pediatric Expansion Study

Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)

A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD